Transplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationBone Marrow TransplantationGraft vs Host DiseaseTransplantation ConditioningLiver TransplantationTransplantation, AutologousTransplantation ChimeraHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationGraft SurvivalKidney TransplantationTissue DonorsStem CellsTreatment OutcomeHeart TransplantationGraft vs Tumor EffectRecurrenceGraft vs Leukemia EffectTransplantation, IsogeneicGraft RejectionTransplantation ImmunologyHistocompatibility TestingImmunosuppressive AgentsBusulfanLung TransplantationRemission InductionLeukemiaHistocompatibilityWhole-Body IrradiationRetrospective StudiesMyeloablative AgonistsVidarabineT-LymphocytesHematopoietic Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunosuppressionLeukemia, Myeloid, AcuteIslets of Langerhans TransplantationTime FactorsOrgan TransplantationSurvival AnalysisCytomegalovirus InfectionsCombined Modality TherapyLymphocyte DepletionCord Blood Stem Cell TransplantationSkin TransplantationIsoantigensCell TransplantationSurvival RateAnemia, AplasticHematopoietic Stem Cell MobilizationLymphocyte Culture Test, MixedTransplantationSiblingsPrecursor Cell Lymphoblastic Leukemia-LymphomaPancreas TransplantationCyclophosphamideMultiple MyelomaAntilymphocyte SerumSalvage TherapyMyelodysplastic SyndromesTransplantation ToleranceNeoplasm, ResidualMinor Histocompatibility AntigensAcute DiseaseChimerismLiving DonorsHLA AntigensMice, Inbred C57BLFollow-Up StudiesMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34Transplantation, HeterotopicCyclosporineAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionVirus ActivationLymphocyte TransfusionCytomegalovirusHepatic Veno-Occlusive DiseaseGraft vs Host ReactionMice, Inbred BALB CLymphocyte ActivationDisease-Free SurvivalLymphoma, Non-HodgkinBone Marrow CellsPrognosisHematologic DiseasesCytotoxicity, ImmunologicActuarial AnalysisMesenchymal Stem Cell TransplantationLeukemia, MyeloidCells, CulturedInfectionCytarabineFlow CytometryOpportunistic Infections